Last reviewed · How we verify
L brevis
At a glance
| Generic name | L brevis |
|---|---|
| Also known as | Oral probiotic |
| Sponsor | Universidade de Passo Fundo |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease (PHASE2)
- Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A (PHASE4)
- Effect of a Probiotic Formula in Mild Cognitive Impairement (NA)
- Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients (NA)
- Levilactobacillus Brevis Oral Health (NA)
- Minimally Invasive Calcaneal Fracture Fixation vs Standard Lateral Approach (NA)
- Acute and Chronic Effects of Ecologic Barrier© on Mood and Cognition (NA)
- Treating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |